Menstrual irregularities and sex hormones in female patients treated with conventional antipsychotics for more than 5 years

Clinical Psychopharmacology and Neuroscience

Volumn 8, Issue 1, 2010, Pages 21-25

  Kim, Jihyeon ^a   Kim, Suyeon ^a   Kim, Sohee ^a   Choi, Sohyun ^a  

^a Yong in Mental Hospital   (South Korea)

Author keywords

Antipsychotics; Estradiol; Menstruation; Prolactin

Indexed keywords

BENZODIAZEPINE; BROMPERIDOL; CARBAMAZEPINE; CHLORPROMAZINE; CLONAZEPAM; EMONAPRIDE; ESTRADIOL; HALOPERIDOL; LITHIUM; LORAZEPAM; NEUROLEPTIC AGENT; PERPHENAZINE; PROLACTIN; SULPIRIDE; TRIFLUOPERAZINE; VALPROIC ACID; ZUCLOPENTHIXOL;

ADULT; AMENORRHEA; ARTICLE; DISEASE COURSE; DISEASE DURATION; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLICULAR PHASE; HUMAN; HYPERPROLACTINEMIA; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; MENTAL DEFICIENCY; MENTAL PATIENT; PROLACTIN BLOOD LEVEL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; THERAPY EFFECT; TREATMENT DURATION;

EID: 77952037217     PISSN: 17381088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Clemens JA, Smalstig EB, Sawyer BD. Antipsychotic drugs stimulate prolactin release. Psychopharmacologia 1974;40:123-127.
2. Mancini AM, Guitelman A, Vargas CA, Debeljuk L, Aparicio NJ. Effect of sulpiride on serum prolactin levels in humans. J Clin Endocrinol Metab 1976;42:181-184.
3. Meltzer HY, Fang VS. The effect of neuroleptics on serum prolactin in schizophrenic patients. Arch Gen Psychiatry 1976;33:279-286.
4. Rubin RT. Prolactin and schizophrenia. In: Meltzer HY, editor, Psychopharmacology: The Third Generation of Progress. New York: Raven Press;1987. p.803-808.
5. Petty RG. Prolactin and antipsychotic medications: mechanism of action. Schizophr Res 1999;35(Suppl):S67-S73.
6. Vance ML. Neuroendocrinology: New directions in the treatment of hyperprolactinemia. Endocrinologist 1997;7:153-159.
7. Corenblum B. Disorders of prolactin secretion. In: Copeland LJ, editor. Textbook of Gynecology. Philadelphia: W.B. Saunders;1993. p.447-467.
8. Smith S. Effects of antipsychotics on sexual and endocrine function in women: implications for clinical practice. J Clin Psychopharmacol 2003;23(3 Suppl 1):S27-S32. (Pubitemid 36807785)
9. Polishuk WZ, Kulcsar S. Effects of chlorpromazine on pituitary function. J Clin Endocrinol Metab 1956;16:292-293.
10. Ghadirian AM, Chouinard G, Annable L. Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients. J Nerv Ment Dis 1982;170:463-467. (Pubitemid 12051650)
11. Prentice DS, Deakin JFW. Role of neuroleptic drugs and organic mechanisms in the aetiology of menstrual irregularities in schizophrenic women. Schizophr Res 1992;6:114.
12. Sullivan G, Lukoff D. Sexual side effects of antipsychotic medication: evaluation and interventions. Hosp Community Psychiatry 1990;41:1238-1241. (Pubitemid 20368363)
13. Smith S, Wheeler MJ, Murray R, O'Keane V. The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis. J Clin Psychopharmacol 2002;22:109-114. (Pubitemid 34289384)
14. Magharious W, Goff DC, Amico E. Relationship of gender and menstrual status to symptoms and medication side effects in patients with schizophrenia. Psychiatry Res 1998;77:159-166. (Pubitemid 28157267)
15. Canuso CM, Goldstein JM, Wojcik J, Dawson R, Brandman D, Klibanski A, et al. Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder. Psychiatry Res 2002;111:11-20. (Pubitemid 34879071)
16. Meaney AM, Smith S, Howes OD, O'Brien M, Murray RM, O'Keane V. Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia. Br J Psychiatry 2004;184:503-508. (Pubitemid 38725710)
17. th ed. Philadelphia:Lippincott Williams & Wilkins;2006. p.461, 1036.
18. th ed. Philadelphia:Lippincott Wiliams & Wilkins;2007. p. 1047.
19. Gerlach J, Behnke K, Heltberg J, Munk-Anderson E, Nielsen H. Sulpiride and haloperidol in schizophrenia: a double-blind cross-over study of therapeutic effect, side effects and plasma concentrations. Br J Psychiatry 1985;147:283-288. (Pubitemid 16255919)
20. Riecher-Rössler A, Häfner H, Stumbaum M, Maurer K, Schmidt R. Can estradiol modulate schizophrenic symptomatology? Schizophr Bull 1994;20:203-214. (Pubitemid 24071103)
21. Green AI, Brown WA. Prolactin and neuroleptic drugs. Neurol Clin 1988;6:213-223.
22. McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas 1992;14:103-115.
23. Marken PA, Haykal RF, Fisher JN. Management of psychotropic-induced hyperprolactinemia. Clin Pharm 1992;11:851-856.